Mutual Fund Equity Report fund seekers may want to consider taking a look at Fidelity Series Growth Company (FCGSX). FCGSX holds a Zacks Mutual Fund Rank of 3 (Hold), which is based on nine forecasting factors like size, cost, and past performance.History of Fund/ManagerFCGSX finds itself in the Fidelity family, based out of Boston, MA. The Fidelity Series Growth Company made its debut in November of 2013 and FCGSX has managed to accumulate roughly $11.90 billion in assets, as of the most recently available information. The fund is currently managed by Steven Wymer who has been in charge of the fund since November of 2013.PerformanceObviously, what investors are looking for in these funds is strong performance relative to their peers. This fund has delivered a 5-year annualized total return of 15.38%, and it sits in the top third among its category peers. But if you are looking for a shorter time frame, it is also worth looking at its 3-year annualized total return of 17.99%, which places it in the top third during this time-frame.When looking at a fund's performance, it is also important to note the standard deviation of the returns. The lower the standard deviation, the less volatility the fund experiences. Over the past three years, FCGSX's standard deviation comes in at 26.39%, compared to the category average of 23.37%. The fund's standard deviation over the past 5 years is 23.61% compared to the category average of 20.72%. This makes the fund more volatile than its peers over the past half-decade.Risk FactorsThe fund has a 5-year beta of 1.17, so investors should note that it is hypothetically more volatile than the market at large. Alpha is an additional metric to take into consideration, since it represents a portfolio's performance on a risk-adjusted basis relative to a benchmark, which in this case, is the S&P 500. FCGSX's 5-year performance has produced a positive alpha of 3.84, which means managers in this portfolio are skilled in picking securities that generate better-than-benchmark returns.HoldingsExamining the equity holdings of a mutual fund is also a valuable exercise. This can show us how the manager is applying their stated methodology, as well as if there are any inherent biases in their approach. For this particular fund, the focus is largely on equities that are traded in the United States.As of the last filing date, the mutual fund has 98.43% of its assets in stocks, with an average market capitalization of $439.86 billion. The fund has the heaviest exposure to the following market sectors: Technology Retail Trade Turnover is 29%, which means this fund makes fewer trades than comparable funds.ExpensesFor investors, taking a closer look at cost-related metrics is key, since costs are increasingly important for mutual fund investing. Competition is heating up in this space, and a lower cost product will likely outperform its otherwise identical counterpart, all things being equal. In terms of fees, FCGSX is a no load fund. It has an expense ratio of 1.12% compared to the category average of 0.99%. FCGSX is actually more expensive than its peers when you consider factors like cost.This fund requires a minimum initial investment of $0, while there is no minimum for each subsequent investment.Bottom LineOverall, Fidelity Series Growth Company ( FCGSX ) has a neutral Zacks Mutual Fund rank, and in conjunction with its comparatively strong performance, average downside risk, and higher fees, Fidelity Series Growth Company ( FCGSX ) looks like a somewhat average choice for investors right now.For additional information on this product, or to compare it to other mutual funds in the Mutual Fund Equity Report, make sure to go to www.zacks.com/funds/mutual-funds for additional information. For analysis of the rest of your portfolio, make sure to visit Zacks.com for our full suite of tools which will help you investigate all of your stocks and funds in one place. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Get Your Free (FCGSX): Fund Analysis ReportTo read this article on Zacks.com click here.Zacks Investment Research